DOSSIER · UPDATED 18 NOV 2025

Ryne Biotechnology

Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States.

ryne-bio.com ↗Claim this profile

Founded: 2022
Headcount: 11
Open roles: 0
Last raised: Series A · $82M

SECTION I · THE BRIEF

Inside Ryne Biotechnology

Brief #86539Updated 18 NOV 2025SAN DIEGOMEDICAL ORGANIZATIONSSERIES A

Employbl Dossier

Ryne Biotechnology

Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States.

Founded: 2022
Headcount: 11
Open roles: 0
Last raised: Series A · $82M

Section II · Premium ProfileMembers only

01Engineering interview process at Ryne BiotechnologyLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Ryne Biotechnology brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Jeffrey Kordower

Carter Cliff

OPEN ROLES

Hiring at Ryne Biotechnology

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $89,000,000